Literature DB >> 22542913

Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective.

Sobha Sivaprasad1, Bhaskar Gupta, Roxanne Crosby-Nwaobi, Jennifer Evans.   

Abstract

The alarming rise in diabetes prevalence is a global public health and economic problem. Diabetic retinopathy is the most common complication of diabetes and the leading cause of blindness among working-age populations in the Western world. Screening and prompt treatment of diabetic retinopathy are not top priorities in many regions of the world, because the impacts of other causes of preventable blindness remain an issue. Ethnicity is a complex, independent risk factor for diabetic retinopathy. Observations from white populations cannot be extrapolated fully to other ethnic groups. The prevalence of diabetic retinopathy, sight-threatening diabetic retinopathy, and clinically significant macular edema are higher in people of South Asian, African, Latin American, and indigenous tribal descent compared to the white population. Although all ethnic groups are susceptible to the established risk factors of diabetic retinopathy-such as length of exposure and severity of hyperglycemia, hypertension, and hyperlipidemia-ethnic-specific risk factors also may influence these rates. Such risk factors may include differential susceptibility to conventional risk factors, insulin resistance, differences in anthropometric measurements, truncal obesity, urbanization, variations in access to healthcare systems, genetic susceptibility, and epigenetics. The rates of nonproliferative diabetic retinopathy appear to be declining in the United States, supporting the observation that better medical management of diabetes and prompt treatment of sight-threatening diabetic retinopathy substantially improve the long-term diabetic retinopathy incidence; studies from other parts of the world are limited and do not mirror this finding, however. We examine the ethnicity and region-based prevalence of diabetic retinopathy around the world and highlight the need to reinforce ethnicity-based screening and treatment thresholds in diabetic retinopathy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542913     DOI: 10.1016/j.survophthal.2012.01.004

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  104 in total

1.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

Review 2.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

Review 3.  Blood pressure control for diabetic retinopathy.

Authors:  Diana V Do; Xue Wang; Satyanarayana S Vedula; Michael Marrone; Gina Sleilati; Barbara S Hawkins; Robert N Frank
Journal:  Cochrane Database Syst Rev       Date:  2015-01-31

4.  Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application.

Authors:  Klaus Pollinger; Robert Hennig; Andreas Ohlmann; Rudolf Fuchshofer; Rebecca Wenzel; Miriam Breunig; Joerg Tessmar; Ernst R Tamm; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 5.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

6.  Association measures for bivariate failure times in the presence of a cure fraction.

Authors:  Lajmi Lakhal-Chaieb; Thierry Duchesne
Journal:  Lifetime Data Anal       Date:  2016-06-23       Impact factor: 1.588

7.  Automatic differentiation of color fundus images containing drusen or exudates using a contextual spatial pyramid approach.

Authors:  Mark J J P van Grinsven; Thomas Theelen; Leonard Witkamp; Job van der Heijden; Johannes P H van de Ven; Carel B Hoyng; Bram van Ginneken; Clara I Sánchez
Journal:  Biomed Opt Express       Date:  2016-02-02       Impact factor: 3.732

Review 8.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

9.  Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics.

Authors:  Eric K Chin; Bruna V Ventura; Kai-Yin See; Joann Seibles; Susanna S Park
Journal:  Telemed J E Health       Date:  2013-11-12       Impact factor: 3.536

10.  South Asian diabetic macular oedema treated with ranibizumab (ADMOR)-real-life experience.

Authors:  F Ghanchi; C A Hazel
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.